Genocea Biosciences (NASDAQ:GNCA) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note issued to investors on Sunday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.24. […]
StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note issued to investors on Sunday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.24. […]
